HLI Houlihan Lokey (HLI) Insider Trading, Ownership & Congress Trades
Financial Services · Investment advice · CIK 0001302215
C-suite buying · 1Congress · 1Form 144 · 1
Funds added, last quarter
234
13F, latest reported quarter
Conversions, 180 days
2
Codes C/M, not in net · $0 priced
What the filings say about HLI
Insiders, 180 days
-$581.0K net sold
1 buyer · 2 sellers · 0% of sales under a 10b5-1 plan
Congress, 1 year
1 bought · 0 sold
Latest: purchase, 2026-08-07
Planned sales (Form 144), 90 days
$140.1K
1 notice
Houlihan Lokey insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, HOULIHAN LOKEY, INC. insiders sold a net $581.0K of stock across 54 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- 12 earlier Form 4 trades (code P or S) here by this insider (12 sales), the last on Apr 1, 2026.
- No other insider sold within 30 days.
- 234 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: GENERAL COUNSEL CRAIN CHRISTOPHER M sold about $140.2K of HLI on Sep 10, 2026; 234 funds added in the latest 13F quarter.Context
- 3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Nov 7, 2024.
- The trade is 100.0% of the 4,020 shares held after it.
- No other insider bought within 30 days.
- 234 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Financial Officer ALLEY J LINDSEY bought about $500.6K of HLI on Aug 3, 2026, the largest insider purchase at the company on our record; 234 funds added in the latest 13F quarter.Context
- 4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on May 19, 2025.
- No other insider sold within 30 days.
- 234 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CO-CHAIRMAN BEISER SCOTT L sold about $941.4K of HLI on May 21, 2026; 234 funds added in the latest 13F quarter.Context
- 11 earlier Form 4 trades (code P or S) here by this insider (11 sales), the last on Jan 2, 2026.
- No other insider sold within 30 days.
- 234 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: GENERAL COUNSEL CRAIN CHRISTOPHER M sold about $71.7K of HLI on Apr 1, 2026; 234 funds added in the latest 13F quarter.Context
- 4 earlier Form 4 trades (code P or S) here by this insider (4 buys), the last on Jun 16, 2022.
- -0.2% median (-1.9% mean) 90-day return after 4 previous buys.
- The trade is 17.9% of the 27,982 shares held after it.
- No other insider sold within 30 days.
- 234 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director SCHRIESHEIM ROBERT A sold about $854.3K of HLI on Feb 6, 2026; 234 funds added in the latest 13F quarter.54 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$581.0K over 180 days
+$360.4K over 90 days · -$941.4K of it by a 10%+ holder
more than 55% of Financial Services
Congress
1 member bought in the last year
the lowest in Financial Services
Funds
234 funds bought in last quarter
more than 81% of Financial Services
Revenue
+9.5% year over year
below 51% of Financial Services
Margin
16.3% net margin
more than 66% of Financial Services
Buybacks
$175.4M repurchased, FY to 2026-03-31
more than 70% of Financial Services
Short interest
4.5% of the float short (float per yahoo 2026-10-26) · 2.6 days to cover · settled 2026-09-30
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch HLI
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-32.5%12M
Insider buyInsider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns HLI: institutional holders (13F)
13F holdings, latest reported quarter
5,240,406 sh
$702.9M
2,774,115 sh
$372.1M
2,439,724 sh
$327.2M
2,426,619 sh
$325.5M
2,172,720 sh
$291.4M
Congress trades in HLI
STOCK Act disclosures, US House only, filed up to 45 days after the trade
Bought 2026-08-07 · disclosed 34 days later
$1,001 - $15,000
Bought 2026-07-16 · disclosed 50 days later
$1,001 - $15,000
Bought 2026-03-03 · disclosed 35 days later
$1,001 - $15,000
Sold 2025-06-04 · disclosed 14 days later
$1,001 - $15,000
Sold 2025-04-09 · disclosed 35 days later
$1,001 - $15,000
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
HLI planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
CHRISTOPHER MADISON CRAIN
Filed 2026-09-10
$140.1K
HLI mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Virtus KAR Small-Cap Value Series
$2.1M position · as of 2026-06-30
4.0%
Virtus KAR Small-Cap Value Fund
$23.9M position · as of 2026-06-30
4.0%
Virtus KAR Mid-Cap Core Fund
$69.1M position · as of 2026-06-30
3.9%
FMI Common Stock Fund
$61.7M position · as of 2026-06-30
3.2%
Virtus KAR Mid-Cap ETF
$1.3M position · as of 2026-07-31
2.9%
Argent Focused Small Cap ETF
$743.4K position · as of 2026-05-29
2.9%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Scott L.Beiser
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2023
$7.0M
$8.7M
$3.9M
+105%
+31%
2022
$7.0M
$7.0M
$4.6M
+37%
-2%
2021
$10.7M
$11.5M
$10.2M
+35%
+15%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $581.0K sold by insiders over 180 days, 234 funds added last quarter, 1 House member(s) bought in 12 months, disclosed weeks after the trade, $140.1K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
HLI financials
Revenue growth
+9.5%
XBRL, annual
Net margin
16.3%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$2.5B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM HLI
| FY Mar 2026 | $2.6B |
| FY Mar 2025 | $2.4B |
| FY Mar 2024 | $1.9B |
| FY Mar 2023 | $1.8B |
| FY Mar 2022 | $2.3B |
| Jun 2026 | $511.0M |
| Mar 2026 | $635.6M |
| Dec 2025 | $717.1M |
| Sep 2025 | $659.5M |
| Jun 2025 | $605.3M |
| Mar 2025 | $666.4M |
| Dec 2024 | $634.4M |
| Sep 2024 | $575.0M |
At each fiscal year end
Single quarter
Net margin, TTM
+16.0%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM HLI
| FY Mar 2026 | +16.2% |
| FY Mar 2025 | +16.7% |
| FY Mar 2024 | +14.6% |
| FY Mar 2023 | +14.0% |
| FY Mar 2022 | +19.3% |
| Jun 2026 | +15.3% |
| Mar 2026 | +15.4% |
| Dec 2025 | +16.3% |
| Sep 2025 | +17.0% |
| Jun 2025 | +16.2% |
| Mar 2025 | +18.3% |
| Dec 2024 | +15.0% |
| Sep 2024 | +16.3% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$484.8M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM HLI
| FY Mar 2026 | $681.8M |
| FY Mar 2025 | $808.9M |
| FY Mar 2024 | $261.7M |
| FY Mar 2023 | $85.5M |
| FY Mar 2022 | $727.9M |
| Jun 2026 | -$342.0M |
| Mar 2026 | $286.8M |
| Dec 2025 | $217.0M |
| Sep 2025 | $323.0M |
| Jun 2025 | -$145.0M |
| Mar 2025 | $343.9M |
| Dec 2024 | $261.7M |
| Sep 2024 | $278.7M |
At each fiscal year end
Single quarter
Debt to equity
0.06x
long-term debt only, 2021-12-31 (54 months older than the period end); equity 2026-06-30
Debt to equity HLI
| FY Mar 2026 | 0.06x |
| FY Mar 2025 | 0.06x |
| FY Mar 2024 | 0.07x |
| FY Mar 2023 | 0.08x |
| FY Mar 2022 | 0.09x |
| Jun 2026 | 0.06x |
| Mar 2026 | 0.06x |
| Dec 2025 | 0.06x |
| Sep 2025 | 0.06x |
| Jun 2025 | 0.06x |
| Mar 2025 | 0.06x |
| Dec 2024 | 0.06x |
| Sep 2024 | 0.07x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
3.74x
TTM operating cash flow over long-term debt only, 2021-12-31 (54 months older than the period end)
Cash flow to debt HLI
| FY Mar 2026 | 5.27x |
| FY Mar 2025 | 6.35x |
| FY Mar 2024 | 2.46x |
| FY Mar 2023 | 1.02x |
| FY Mar 2022 | 5.52x |
| Jun 2026 | 3.74x |
| Mar 2026 | 5.27x |
| Dec 2025 | 5.76x |
| Sep 2025 | 6.12x |
| Jun 2025 | 5.85x |
| Mar 2025 | 6.35x |
| Dec 2024 | 5.36x |
| Sep 2024 | 4.13x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+18.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity HLI
| FY Mar 2026 | +18.8% |
| FY Mar 2025 | +19.9% |
| FY Mar 2024 | +16.2% |
| FY Mar 2023 | +16.6% |
| FY Mar 2022 | +31.0% |
| Jun 2026 | +18.2% |
| Mar 2026 | +18.8% |
| Dec 2025 | +20.5% |
| Sep 2025 | +20.3% |
| Jun 2025 | +20.4% |
| Mar 2025 | +19.9% |
| Dec 2024 | +18.6% |
| Sep 2024 | +18.5% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+11.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets HLI
| FY Mar 2026 | +10.4% |
| FY Mar 2025 | +11.4% |
| FY Mar 2024 | +9.1% |
| FY Mar 2023 | +8.7% |
| FY Mar 2022 | +16.5% |
| Jun 2026 | +11.2% |
| Mar 2026 | +10.4% |
| Dec 2025 | +12.1% |
| Sep 2025 | +12.2% |
| Jun 2025 | +12.7% |
| Mar 2025 | +11.4% |
| Dec 2024 | +11.1% |
| Sep 2024 | +11.1% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+24.0%
operating income after a 26.5% effective tax rate, over long-term debt only, 2021-12-31 (54 months older than the period end) plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital HLI
| FY Mar 2026 | +30.4% |
| FY Mar 2025 | +29.2% |
| FY Mar 2024 | +23.5% |
| FY Mar 2023 | +30.2% |
| FY Mar 2022 | +62.9% |
| Jun 2026 | +24.0% |
| Mar 2026 | +30.4% |
| Dec 2025 | +30.2% |
| Sep 2025 | +28.0% |
| Jun 2025 | +25.4% |
| Mar 2025 | +29.2% |
| Dec 2024 | +24.7% |
| Sep 2024 | +23.7% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
assets or current liabilities not filed
Return on capital employed HLI
| FY Mar 2026 | n/a |
| FY Mar 2025 | n/a |
| FY Mar 2024 | n/a |
| FY Mar 2023 | n/a |
| FY Mar 2022 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
22.02x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing HLI
| FY Mar 2026 | 23.05x |
| FY Mar 2025 | 27.70x |
| FY Mar 2024 | 31.19x |
| FY Mar 2023 | 23.27x |
| FY Mar 2022 | 13.70x |
| Jun 2026 | 22.51x |
| Mar 2026 | 23.05x |
| Dec 2025 | 26.72x |
| Sep 2025 | 33.06x |
| Jun 2025 | 30.24x |
| Mar 2025 | 27.70x |
| Dec 2024 | 33.14x |
| Sep 2024 | 32.31x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no share count filed
Enterprise value HLI
| FY Mar 2026 | n/a |
| FY Mar 2025 | n/a |
| FY Mar 2024 | n/a |
| FY Mar 2023 | n/a |
| FY Mar 2022 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
no share count filed
FCF yield HLI
| FY Mar 2026 | n/a |
| FY Mar 2025 | n/a |
| FY Mar 2024 | n/a |
| FY Mar 2023 | n/a |
| FY Mar 2022 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
130.99x
P/E over trailing EPS growth of 0%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing HLI
| FY Mar 2026 | 3.36x |
| FY Mar 2025 | 0.66x |
| FY Mar 2024 | 3.35x |
| FY Mar 2023 | n/a |
| FY Mar 2022 | 0.33x |
| Jun 2026 | 133.90x |
| Mar 2026 | 3.36x |
| Dec 2025 | 1.09x |
| Sep 2025 | 1.22x |
| Jun 2025 | 0.95x |
| Mar 2025 | 0.66x |
| Dec 2024 | 0.95x |
| Sep 2024 | 1.06x |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2026-03 | 2025-03 | 2024-03 | 2023-03 | |
|---|---|---|---|---|
| Revenue | $2.6B | $2.4B | $1.9B | $1.8B |
| Gross profit | n/a | $772.3M | $571.1M | $557.1M |
| Operating income | $527.0M | $502.6M | $373.2M | $341.7M |
| Net income | $424.0M | $400.0M | $280.0M | $254.0M |
| EPS (diluted) | 6.22 | 5.82 | 4.11 | 3.76 |
| Operating cash flow | $704.1M | $848.6M | $328.5M | $136.3M |
| Cash | $1.2B | $971.0M | $721.2M | $714.4M |
| Buybacks | $175.4M | $52.5M | $25.0M | $48.7M |
| Dividends paid | $174.0M | $165.2M | $148.5M | $140.4M |
SEC XBRL, fiscal years, as known on 2026-10-28
HLI Stock Sonar score 6/7 axes
Find similar shapesCompareHLI ranks highest on financial health (83rd percentile) and profitability (74th), and lowest on growth (49th), among Financial Services peers.
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
HLI filings, in plain words
Are Houlihan Lokey insiders buying or selling HLI?
In the 180 days to 2026-10-28, Houlihan Lokey insiders were net sellers, a net $581.0K: $500.6K of purchases and $1.1M of sales reported on Form 4, by 1 buyer and 2 sellers.
Have members of Congress traded HLI?
Yes. In the year to 2026-10-28, 1 House member disclosed buying HLI and 0 House members disclosed selling it; the latest on record is a purchase by Gilbert Cisneros dated 2026-08-07.
Are there planned insider sales of HLI?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-28, covering $140.1K of stock; the latest, by CHRISTOPHER MADISON CRAIN, was filed 2026-09-10.
Read the full summary
In the 180 days to 2026-10-28, Houlihan Lokey insiders were net sellers of HLI, a net $581.0K across purchases and sales reported on Form 4 by 1 buyer and 2 sellers. Most of that figure, $941.4K, came from a holder of 10% or more rather than an officer or director. In the year to 2026-10-28, 1 member of Congress disclosed buying HLI and 0 members disclosed selling it; the latest on record is a purchase by Gilbert Cisneros dated 2026-08-07. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-28, covering $140.1K of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
